Karen Segura Dávila

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology

Vall Hebron Institut de Recerca

Karen Segura Dávila

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology

Vall Hebron Institut de Recerca

Related news

Professionals que participen al projecte TACTIC

TACTIC project groups present new advances

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

A questionnaire and self-administered tests detect the progression of multiple sclerosis

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Dr. Xavier Montalban, Dr. Mar Tintoré and Dr. René Carvajal

Age and treatment may predict risk of multiple sclerosis reactivation

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.